Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001–2018)

Fig. 3

Spatial and temporal changes in the prevalence of ac mdr86ASN lumefantrine tolerance marker, df crt76LYS lumefantrine tolerance marker, gi the quintuple SP resistance marker and k the kelch13 markers in Ehlanzeni District, Mpumalanga Province, South Africa (2001–2018)

Back to article page